PFN2

Across TCGA pan-cancer cohorts, PFN2 mass-spec protein differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of PFN2’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where PFN2 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types PFN2 is over-expressed in tumor, although a few such as COAD and CCRCC show the opposite, repressed pattern.

COAD, CCRCC, and LSCC are the cancer types where PFN2 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in PFN2 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Male	III,IV	−0.922	<.001	11	view →
CCRCC	Male	III,IV	−0.685	<.001	11	view →
LSCC	Male	All	+1.160	<.001	9	view →
HNSC	Male	IV	+0.681	<.001	8	view →
LUAD	Male	All	+0.429	<.001	7	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

PFN2–COAD

Open the COAD breakdown →